Rethinking the Role of Radiation Therapy in the Management of Epithelial Ovarian Cancer

Rethinking the Role of Radiation Therapy in the Management of Epithelial Ovarian Cancer

Radiation has been relegated to a palliative role in the management of epithelial ovarian cancer (EOC). Contemporary radiation techniques, including intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and image-guided radiation therapy, enable conformal treatmen...

Full description

Bibliographic Details
Main Authors:	Geraldine Jacobson, Valerie Galvan-Turner
Format:	Article
Language:	English
Published:	MDPI AG 2020-04-01
Series:	Diagnostics
Subjects:	ovarian cancer radiation therapy stereotactic body radiation (SBRT)
Online Access:	https://www.mdpi.com/2075-4418/10/4/211

Similar Items

CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer
by: Michael Waters, et al.
Published: (2024-01-01)

Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety
by: Isaure Roquette, et al.
Published: (2022-08-01)

Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy
by: Paulina M. Gutkin, et al.
Published: (2023-03-01)

Stereotactic Body Radiation Therapy (SBRT) for a Patient with a Myocardial Metastasis: A Case Report
by: Aneesh Dhar, et al.
Published: (2021-01-01)

Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia
by: Berend J. Slotman, et al.
Published: (2022-08-01)

Risk factors of local control in adrenal metastases treated by stereotactic body radiation therapy - a systematic review and meta-analysis
by: Xuehong Liao, et al.
Published: (2023-11-01)

MR-guided stereotactic radiation therapy for head and neck cancers
by: He Wang, et al.
Published: (2024-05-01)

Rationale for Combing Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors in Medically Inoperable Early-Stage Non-Small Cell Lung Cancer
by: Alexander Chi, et al.
Published: (2022-06-01)

Effect of Synchronous Versus Sequential Regimens on the Pharmacokinetics and Biodistribution of Regorafenib with Irradiation
by: Tung-Hu Tsai, et al.
Published: (2021-03-01)

Oligometastatic Squamous Cell Transformation From Metastatic Prostate Adenocarcinoma Treated With Systemic and Focal Therapy: A Case Report
by: Karen Autio, et al.
Published: (2022-08-01)

Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy
by: Doris N. Rusu, et al.
Published: (2023-12-01)

Adoption of Biologically Effective Dose of the Non-Target Lung Volume to Predict Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy With Variable Fractionations for Lung Cancer
by: Yuxin Jiao, et al.
Published: (2020-07-01)

Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancer
by: Rishabh K. Simhal, et al.
Published: (2022-12-01)

Ventricular tachycardia ablation through radiation therapy (VT-ART) consortium: Concept description of an observational multicentric trial via matched pair analysis
by: Francesco Cellini, et al.
Published: (2023-02-01)

Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options
by: Noureddine Boujelbene, et al.
Published: (2013-05-01)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)

Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy
by: Matthew D. Hall, et al.
Published: (2023-01-01)

Considerations on surgery invasiveness and response and toxicity patterns in classic palliative radiotherapy for acrometastases of the hand: a hint for a potential role of stereotactic body radiation therapy? A case report and literature review
by: Gianluca Ferini, et al.
Published: (2023-06-01)

Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer
by: Lindsey Gallagher, et al.
Published: (2023-10-01)

Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose–Volume–Effect Correlation
by: Kim Melanie Kraus, et al.
Published: (2022-06-01)

Recall of reactive cutaneous capillary endothelial proliferation (RCCEP) induced by stereotactic body radiation therapy (SBRT) in a patient with lung squamous cell carcinoma
by: Rong Ma, et al.
Published: (2022-10-01)

Induction FOLFIRINOX followed by stereotactic body radiation therapy in locally advanced pancreatic cancer
by: Jae Hyup Jung, et al.
Published: (2022-12-01)

Upfront Chemotherapy Followed by Stereotactic Body Radiation Therapy with or without Surgery in Older Patients with Localized Pancreatic Cancer: A Single Institution Experience and Review of the Literature
by: Abhinav V. Reddy, et al.
Published: (2022-01-01)

Definitive Treatment of Early-Stage Non-Small Cell Lung Cancer with Stereotactic Ablative Body Radiotherapy in a Community Cancer Center Setting
by: Cory eHeal, et al.
Published: (2015-06-01)

Neoadjuvant SBRT combined with immunotherapy in NSCLC: from mechanisms to therapy
by: Yanhong Shi, et al.
Published: (2023-08-01)

The role of stereotactic body radiation therapy in the treatment of colorectal liver metastases
by: Marinković Mladen, et al.
Published: (2022-01-01)

SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines
by: Matthew eBernetich, et al.
Published: (2014-11-01)

Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine
by: Eunji Kim, et al.
Published: (2023-09-01)

Radiation-Induced Dyspnea in Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy
by: Laura Cella, et al.
Published: (2021-07-01)

Electromagnetic Transmitter-Based Prostate Gating for Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy: An Evaluation of Intrafraction Motion
by: Berardino De Bari, et al.
Published: (2024-02-01)

Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma
by: Rohit K. Raj, et al.
Published: (2023-12-01)

Image-Guided Robotic Radiosurgery for the Management of Intramedullary Spinal Cord Metastases—A Multicenter Experience
by: Felix Ehret, et al.
Published: (2021-01-01)

Stereotactic Body Radiation Therapy after Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study
by: Rogier Baak, et al.
Published: (2021-08-01)

Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer
by: Tamir N. Sholklapper, et al.
Published: (2022-03-01)

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer
by: Izabela Zarębska, et al.
Published: (2023-10-01)

Stereotactic Radiation Therapy for Brain Metastases: Factors Affecting Outcomes and Radiation Necrosis
by: Angela Barillaro, et al.
Published: (2023-03-01)

Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer
by: Abigail N. Pepin, et al.
Published: (2022-01-01)

Role of Radiation Therapy in the Management of Renal Cell Cancer
by: Angel I. Blanco, et al.
Published: (2011-10-01)

Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study
by: Hiroshi Onishi, et al.
Published: (2018-08-01)

Multi-institutional experience of MR-guided stereotactic body radiation therapy for adrenal gland metastases
by: Matthew Mills, et al.
Published: (2024-03-01)